Varex Imaging Corporation reported $865M of revenue over the trailing twelve months. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $865M (to Q3 2026). Net income: $22M, trailing twelve months to Q3 2026. Free cash flow: −$20M, trailing twelve months to Q3 2026. Operating margin: 8.4%, trailing twelve months to Q3 2026.

VREXVarex Imaging Corporation

Healthcare

$10.29+29% 1Y

$10.29

$9.3252 weeks$18.58

VREX as reported

Varex Imaging Corporation reported $865M of revenue over the trailing twelve months. 11 reported series are charted on this page, each one as filed.

$865M

Revenue, trailing twelve months · to Q3 2026 · every figure below is as filed, with no scoring applied

Net income: $22M
Net income · −117% year on year · trailing twelve months to Q3 2026
Free cash flow: −$20M
Free cash flow · −155% year on year · trailing twelve months to Q3 2026
Operating margin: 8.4%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for VREX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$865M	n/a	Q3 2026
Net income	$22M	−117%	Q3 2026
EPS	$0.53	−116%	Q3 2026
Gross margin	34%	n/a	Q3 2026
Operating margin	8.4%	n/a	Q3 2026
Net margin	2.5%	n/a	Q3 2026
ROE	−11%	n/a	Q3 2026
ROA	−4.5%	n/a	Q3 2026
ROIC	−0.38%	n/a	Q3 2026
Free cash flow	−$20M	−155%	Q3 2026
P/E	34.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.